Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy

NCT ID: NCT06464978

Last Updated: 2024-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

382 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-30

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center, prospective, randomized controlled study aimed at compareing the impact of stapler reinforcement patches versus standard staplers on postoperative complications in gastrojejunostomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study compares stapler reinforcement patches with standard staplers in gastrojejunostomy to reduce postoperative complications. It aims to demonstrate the effectiveness and safety of these patches in preventing anastomotic leakage and other related complications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancer Gastrostomy Anastomotic Leakage Postoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly assigned to either the experimental group receiving the stapler reinforcement patches or the control group undergoing standard procedures without reinforcement patches.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Participants and outcomes assessors will be blinded to the group assignments. Surgeons will be aware of the group assignments but will not disclose this information to the participants or the outcomes assessors.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stapler Reinforcement Patch Group

Participants in this group will receive gastrojejunostomy with the use of stapler reinforcement patches.

Group Type EXPERIMENTAL

Stapler Reinforcement Patch

Intervention Type DEVICE

Participants in this group will receive gastrojejunostomy with the use of stapler reinforcement patches.

Standard Stapler Group

Participants in this group will receive gastrojejunostomy with the use of standard staplers.

Group Type ACTIVE_COMPARATOR

Standard Stapler

Intervention Type DEVICE

Participants in this group will receive gastrojejunostomy with the use of Standard Stapler

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stapler Reinforcement Patch

Participants in this group will receive gastrojejunostomy with the use of stapler reinforcement patches.

Intervention Type DEVICE

Standard Stapler

Participants in this group will receive gastrojejunostomy with the use of Standard Stapler

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 85 years.
* Pathologically diagnosed with gastric cancer and suitable for distal gastrectomy or subtotal gastrectomy.
* ECOG performance status of 0 or 1.
* ASA (American Society of Anesthesiologists) classification of I-III.
* Voluntary signed informed consent from the participant or their legal representative.

Exclusion Criteria

* Evidence of potential distant metastasis found preoperatively.
* History of other malignancies diagnosed within the past 5 years, or any malignancy treated with chemotherapy or radiotherapy.
* Significant contraindications for surgery (e.g., severe liver or kidney dysfunction).
* Participation in any other clinical trial within the last 6 months.
* Participants or their legal representatives unwilling to sign the informed consent or comply with the study protocol.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guang'an Central Hospital

UNKNOWN

Sponsor Role collaborator

Pengan County People's Hospital

OTHER

Sponsor Role collaborator

Yilong County people's Hospital

UNKNOWN

Sponsor Role collaborator

Nanbu Hospital of County Chinese Medicine

OTHER

Sponsor Role collaborator

Langzhong People's Hospital

UNKNOWN

Sponsor Role collaborator

Nanchong Central Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yunhong Tian

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yunhong Tian

Nanchong, Sichuan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yunhong Tian, PHD

Role: primary

13508087719

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20240530

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.